Edition:
United Kingdom

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

12.59CNY
13 Dec 2018
Change (% chg)

¥0.23 (+1.86%)
Prev Close
¥12.36
Open
¥12.40
Day's High
¥12.62
Day's Low
¥12.29
Volume
11,290,863
Avg. Vol
5,070,524
52-wk High
¥22.73
52-wk Low
¥12.29

Latest Key Developments (Source: Significant Developments)

China Resources Double-Crane Pharmaceutical's 9-Month Net Profit Up 16.43 Pct Y/Y
Sunday, 28 Oct 2018 

Oct 28 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS 9-MONTH NET PROFIT UP 16.43 PERCENT Y/Y.  Full Article

China Resources Double-Crane Pharmaceutical Says H1 Net Profit Up 12.0 Percent Y/Y
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS H1 NET PROFIT UP 12.0 PERCENT Y/Y.  Full Article

China Resources Double-Crane Pharmaceutical's Board Elects Wang Chuncheng As Chairman
Monday, 25 Jun 2018 

June 25 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS BOARD ELECTS WANG CHUNCHENG AS CHAIRMAN.  Full Article

China Resources Double-Crane Pharmaceutical To Buy Stakes In Two Pharma Firms
Monday, 4 Jun 2018 

June 4 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS IT WINS BID FOR 45 PERCENT STAKE IN HUNAN XIANGZHONG PHARMACEUTICAL FOR 143.9 MILLION YUAN ($22.46 million).SAYS BOARD APPROVES TO BUY 40 PERCENT STAKE IN JINAN PHARMACEUTICAL FIRM FOR 847.7 MILLION YUAN.  Full Article

China Resources Double-Crane Pharmaceutical's Q1 Net Profit Up 27.9 Percent Y/Y
Monday, 23 Apr 2018 

April 23 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS Q1 NET PROFIT UP (NOT DOWN) 27.9 PERCENT Y/Y AT 300.4 MILLION YUAN ($47.63 million).  Full Article

China Resources Double-Crane Pharmaceutical's 2017 Net Profit Up 18.0 Pct At 842.6 Mln Yuan
Wednesday, 14 Mar 2018 

March 14 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>::SAYS 2017 NET PROFIT UP 18.0 PERCENT Y/Y AT 842.6 MILLION YUAN ($133.42 million).  Full Article

China Resources Double-crane Pharmaceutical unit receives GMP certificate
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration .Certificate issued to edaravone manufactured by the unit and the valid period is until Jan. 7, 2023 .  Full Article

China Resources Double-crane Pharmaceutical to set up medical industrial investment LP with partners
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::Says it plans to invest 50 million yuan to set up an medical industrial investment limited partnership worth totaling 2.5 billion yuan, with partners.  Full Article

China Resources Double-Crane Pharmaceutical's 9-month net profit up 20.5 pct y/y
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says its 9-month net profit up 20.5 percent y/y at 724.9 million yuan ($109.34 million).  Full Article

China Resources Double-crane Pharmaceutical to pay FY 2016 annual div on July 17
Monday, 10 Jul 2017 

July 10(Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::* Says it will pay FY 2016 dividend to shareholders of record on July 14.* The company's shares will be traded ex-right and ex-dividend on July 17 and the dividend will be paid on July 17.  Full Article